Abstract

Adult salivary stem/progenitor cells (SSPC) have an intrinsic property to self-renew in order to maintain tissue architecture and homeostasis. Adult salivary glands have been documented to harbor SSPC, which have been shown to play a vital role in the regeneration of the glandular structures postradiation damage. We have previously demonstrated that activation of aldehyde dehydrogenase 3A1 (ALDH3A1) after radiation reduced aldehyde accumulation in SSPC, leading to less apoptosis and improved salivary function. We subsequently found that sustained pharmacological ALDH3A1 activation is critical to enhance regeneration of murine submandibular gland after radiation damage. Further investigation shows that ALDH3A1 function is crucial for SSPC self-renewal and survival even in the absence of radiation stress. Salivary glands from Aldh3a1–/– mice have fewer acinar structures than wildtype mice. ALDH3A1 deletion or pharmacological inhibition in SSPC leads to a decrease in mitochondrial DNA copy number, lower expression of mitochondrial specific genes and proteins, structural abnormalities, lower membrane potential, and reduced cellular respiration. Loss or inhibition of ALDH3A1 also elevates ROS levels, depletes glutathione pool, and accumulates ALDH3A1 substrate 4-hydroxynonenal (4-HNE, a lipid peroxidation product), leading to decreased survival of murine SSPC that can be rescued by treatment with 4-HNE specific carbonyl scavengers. Our data indicate that ALDH3A1 activity protects mitochondrial function and is important for the regeneration activity of SSPC. This knowledge will help to guide our translational strategy of applying ALDH3A1 activators in the clinic to prevent radiation-related hyposalivation in head and neck cancer patients.

Details

Title
Aldehyde dehydrogenase 3A1 deficiency leads to mitochondrial dysfunction and impacts salivary gland stem cell phenotype
Author
Viswanathan, Vignesh 1   VIAFID ORCID Logo  ; Cao, Hongbin 1 ; Saiki, Julie 1 ; Jiang, Dadi 2 ; Mattingly, Aaron 3 ; Nambiar, Dhanya 1 ; Bloomstein, Joshua 1   VIAFID ORCID Logo  ; Yang, Li 1 ; Jiang, Sizun 4   VIAFID ORCID Logo  ; Chamoli, Manish 5   VIAFID ORCID Logo  ; Sirjani, Davud 6 ; Kaplan, Michael 6 ; Holsinger, F Christopher 6 ; Liang, Rachel 1 ; Rie Von Eyben 1 ; Jiang, Haowen 1 ; Li, Guan 1 ; Lagory, Edward 1 ; Feng, Zhiping 7 ; Nolan, Garry 4 ; Ye, Jiangbin 1   VIAFID ORCID Logo  ; Denko, Nicholas 8 ; Knox, Sarah 3   VIAFID ORCID Logo  ; Rosen, Daria-Mochly 7   VIAFID ORCID Logo  ; Le, Quynh-Thu 1   VIAFID ORCID Logo 

 Department of Radiation Oncology, Stanford School of Medicine , Stanford, CA 94305, USA 
 Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX 77030, USA 
 Department of Cell and Tissue Biology, University of California San Francisco , San Francisco, CA 94143, USA 
 Department of Microbiology and Immunology, Stanford University School of Medicine , Stanford, CA 94305, USA 
 Buck Institute for Research on Aging , 8001 Redwood Blvd., Novato, CA 94945, USA 
 Department of Otolaryngology–Head and Neck Surgery, Stanford University School of Medicine , Stanford, CA 94305, USA 
 Department of Chemical and Systems Biology, Stanford University School of Medicine , Stanford, CA 94305, USA 
 The Ohio State University Wexner Medical Center and OSU Comprehensive Cancer Center , Columbus, OH 43210, USA 
Publication year
2022
Publication date
May 2022
Publisher
Oxford University Press
e-ISSN
27526542
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3191358905
Copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the National Academy of Sciences. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.